Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-031074

Chief Executive Officer sold 4,536 shares at $4.21 ($19,115)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Brainard Diana · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-05-18 Sale : show line 1 in the form 10b5-1 −4,536 $4.21 $19,115 916,628 D
Open-market sales · 4,536 sh · avg $4.21 · $19,115
Loading xslF345X04/doc4.xml…